Cidara Therapeutics Inc Banner Image

Cidara Therapeutics Inc

  • Ticker CDTX
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Cidara Therapeutics Inc Logo Image
  • 51-200 Employees
  • Based in San Diego, California
Cidara Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of novel anti-infectives for the treatment of diseases. Its lead product candidate is CD101 IV, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of systemic Candida infections. The company also develops CD101 topical, a topical formulationMore of CD101 for the treatment of recurrent vulvovaginal candidiasis, a prevalent mucosal infection
4.8 / 5.0 (127)

Cidara Therapeutics Inc reports have an aggregate usefulness score of 4.8 based on 127 reviews.

Cidara Therapeutics Inc

Most Recent Annual Report

Cidara Therapeutics Inc
MOST RECENT 2022 Annual Report and Form 10K

Cidara Therapeutics Inc does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports

Cidara Therapeutics Inc Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!